# Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)

> **NCT07212582** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Mahidol University** · enrollment: 304 (estimated)

## Conditions studied

- Critical Illness
- Septic Shock

## Interventions

- **DRUG:** Human Albumin 20% Solution
- **OTHER:** Standard Care (in control arm)

## Key facts

- **NCT ID:** NCT07212582
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 304 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07212582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07212582, "Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07212582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*